Sign inJoin waitlistJoin the waitlist

Lisa Rimsza

Department Chair, Pathology and Laboratory Medicine · University of Arizona College of Medicine-Tucson

Credentials: · · · ·

History

Pathology and Laboratory Medicine Department · University of Arizona College of Medicine-Tucson
Present
Department of Pathology and Laboratory Medicine · University of Arizona College of Medicine-Tucson
Present
University of Arizona College of Medicine-Tucson
Present

University of New Mexico Hemapathology
1999–2000
Internal Medicine
1996–1999
Arizona Health Sciences Center Pathology
1992–1996
University of Arizona College of Medicine
1988–1992
University of Arizona
1984–1988

Research

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
New England Journal of Medicine · 2018 · 1,863 citations
Stromal gene signatures in large-B-cell lymphomas
New England Journal of Medicine · 2008 · 1,470 citations
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Nature · 2010 · 1,361 citations

Wing Chan
71 papers
Elaine Jaffe
69 papers
Dennis Weisenburger
54 papers
RB
Rita Braziel
52 papers
James Cook
42 papers
TG
Timothy Greiner
38 papers
RF
Richard Fisher
35 papers
Jonathan Friedberg
28 papers
KF
Kai Fu
28 papers · 1 as a fellow
RT
Raymond Tubbs
24 papers
Julie Vose
23 papers
Andrew Feldman
22 papers

Grants

Assay Development and Prognostic Model for Predicting Early Clinical Failure in Follicular Lymphoma
National Cancer Institute · UH3
Contact PI · $411K · University of Arizona
2024–2029
AIDS and Cancer Specimen Resource (ACSR)
National Cancer Institute · UM1
PI · $9.6M · George Washington University
2013–2026
Assay Development and Prognostic Model for Predicting Early Clinical Failure in Follicular Lymphoma
National Cancer Institute · UH2
Contact PI · $368.6K · University of Arizona
2024–2026
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma
National Cancer Institute · P01
Contact PI · $10.2M · Mayo Clinic Arizona
2018–2024

Clinical trials

S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Study chair · Completed · Phase 2
SWOG Cancer Research Network
2009–2019
S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone
Study chair · Completed
SWOG Cancer Research Network
2008–2012
SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
Study chair · Completed
SWOG Cancer Research Network
1989–2011